Inside the world of cell therapies

While uptake has been limited, cell therapy’s impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through “off-the-shelf” options. Discover the current market for cancer cell therapies and what biotechs are working on next.

INCLUDED IN THIS TRENDLINE

• Roche digs into off-the-shelf cell therapy with Poseida deal

• Bristol Myers CAR-T therapy cleared by FDA for earlier lymphoma use

• Versant-backed startup launches with plans to broaden cell therapy’s reach